Literature DB >> 31570448

Linking Infection and Prostate Cancer Progression: Toll-like Receptor3 Stimulation Rewires Glucose Metabolism in Prostate Cells.

Maria Chiara Magnifico1, Alberto Macone1, Marina Marani1, Amani Bouzidi1, Giorgio Giardina1, Serena Rinaldo1, Francesca Cutruzzolà2, Alessio Paone1.   

Abstract

BACKGROUND/AIM: The connection between prostate cancer and inflammation has been proposed many years ago, but very little is known about the metabolic adaptations of prostate cells in case of infection or inflammation. The aim of this study was to examine the effect of the stimulation of Toll-like receptor 3 (TLR3) on the metabolism of prostate cancer (PCa) cell lines and benign prostate cells.
MATERIALS AND METHODS: Cytofluorimetry, qRT-PCR, western blot and Gas-chromatography/Mass-spectrometry were used.
RESULTS: Reprogramming of glucose utilization involving hypoxia-inducible factor 1-alpha (HIF-1α) and the extracellular adenosine axis was observed. TLR3 stimulation synergized with adenosine receptor A2b on PCa cells, and induced a strong production of lactate, exacerbating the Warburg effect. Moreover, stimulation of benign prostate cells with poly I:C reduced lactate secretion, a characteristic typical of the neoplastic transformation.
CONCLUSION: TLR3 stimulation promotes metabolic adaptations likely involved in the mechanisms of disease onset and progression. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  A2b; CD73; Inflammation; Warburg effect; adenosine; metabolism

Mesh:

Substances:

Year:  2019        PMID: 31570448     DOI: 10.21873/anticanres.13747

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

Review 1.  Purinergic Signaling in the Hallmarks of Cancer.

Authors:  Anaí Del Rocío Campos-Contreras; Mauricio Díaz-Muñoz; Francisco G Vázquez-Cuevas
Journal:  Cells       Date:  2020-07-03       Impact factor: 6.600

Review 2.  Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistance.

Authors:  Hamid Aria; Marzieh Rezaei; Shima Nazem; Abdolreza Daraei; Ghasem Nikfar; Behnam Mansoori; Maryam Bahmanyar; Alireza Tavassoli; Mohammad Kazem Vakil; Yaser Mansoori
Journal:  Front Immunol       Date:  2022-08-22       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.